MetaCap

Elanco Animal Health Incorporated (ELAN)

NYSE: ELANHealth CareBiotechnology: Pharmaceutical PreparationsUSD

25.74-0.55 (-2.09%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ELAN stock chart

Technical analysis

Key statistics

All statistics
Market cap
$12.87B
EPS (TTM)
-$0.30
52-week range
19.40 – 27.98
Day range
25.58 – 26.93
Volume / Avg
5.83M / 5.32M
Beta
—

52-week range

$19.40$27.98

ELAN stock today

Elanco Animal Health (ELAN) closed at $25.74 on Nov 20, down 2.09% (-$0.55), versus the S&P 500's 3.70% decline. At this level, ELAN sits in the middle of its 52-week range of $19.40 to $27.98: 8.0% below the high, set on Aug 5, 2026 and 32.7% above the low. ELAN is up 13.7% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 15.7%.

Elanco Animal Health has posted a net loss over the last twelve months (EPS of -$0.30), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Elanco Animal Health

Company profile

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. The company offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Credelio Family, Interceptor Plus, Drontal family, and Drontal Plus; vaccines portfolio that provides differentiated prevention coverage for a number of important pet health risks; and therapeutics portfolio for the treatment of pain, otitis, cardiovascular, and dermatology indications, as well as osteoarthritis for dogs and cats under the Galliprant trademark. It also provides farm animal products that help farmers improve animal health and wellbeing, and raise livestock, such as cattle, swine, and poultry.

Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Jeffrey N. Simmons
Headquarters
Indianapolis, IN
Employees
9,400
IPO year
2018
Website
elanco.com

Financial highlights

Full financials

In fiscal 2025, Elanco Animal Health generated $4.71 billion in revenue, up 6.2% from fiscal 2024, its 3rd consecutive year of revenue growth. Elanco Animal Health reported a net loss of $232.0 million, compared with net income of $338.0 million a year earlier. Gross margin was 55.0% (up from 54.9%).

Elanco Animal Health annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$4.71B$4.44B$4.42B$4.41B$4.76B
Growth+6.22%+0.50%+0.14%-7.41%+45.55%
Net income$-232.00M$338.00M$-1.23B$-78.00M$-483.00M
EPS (diluted)$-0.47$0.68$-2.50$-0.16$-0.99

Analyst forecast

Forecast

Consensus (16 analysts)

buy

Avg. price target

$31.00+20.44%

  • Strong buy 4
  • Buy 9
  • Hold 3
  • Sell 0
  • Strong sell 0

Target range

Low $25.00High $35.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 6, 2026
EPS actual vs est.
$0.04 vs $0.20
Surprise
-80.00%

ELAN news

All ELAN news

Elanco Animal Health peers

Health Care sector
ELAN peer companies
CompanyPrice% ChgMarket capCompare
RDYDr. Reddy's Laboratories Ltd14.89+0.40%$12.41Bvs ELAN
BMRNBioMarin Pharmaceutical Inc.60.41-1.64%$11.70Bvs ELAN
JAZZJazz Pharmaceuticals plc230.26-2.62%$14.78Bvs ELAN
BBIOBridgeBio Pharma Inc.76.03-2.75%$14.81Bvs ELAN
TGTXTG Therapeutics Inc.63.34-2.37%$9.57Bvs ELAN
ASNDAscendis Pharma A/S252.73-1.26%$16.58Bvs ELAN
SYRESpyre Therapeutics Inc.93.47-4.26%$8.88Bvs ELAN
MDGLMadrigal Pharmaceuticals Inc.379.10-4.45%$8.81Bvs ELAN

Indexes, lists and sector

Elanco Animal Health stock FAQ

What is Elanco Animal Health's stock price today?

ELAN last traded at $25.74 as of Nov 20, 4:00 PM EST, down 2.09% on the day. Prices are delayed at least 15 minutes.

Who is Elanco Animal Health's CEO?

Mr. Jeffrey N. Simmons is the chief executive officer of Elanco Animal Health Incorporated, which has about 9,400 employees.

What is the ELAN 52-week high?

The 52-week high for ELAN is $27.98 and the 52-week low is $19.40. The stock is currently 8.0% below its high.

Compare ELAN